-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
June 20, 2013 - Comparator(s): All other treatment options
Outcome(s): Increases in short- and long-term benefits in … reduction or elimination of low back pain, improvements in functioning and
quality of life; decreases in short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - Overall, in patients with chronic (mainly neuropathic) pain with short-term treatment (4
weeks to < … Key Question 1: Benefits of cannabinoids for chronic pain compared with placebo in the
short term (4 … Key Question 2: Harms of cannabinoids for chronic pain compared with placebo in the
short term (4 weeks … Our methods
include categorizing the duration of studies as short-, intermediate-, and long-term. … The
findings are applicable to short-term treatment (4 weeks to <6 months) in patients with chronic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
May 01, 2019 - effectiveness of
available treatment strategies for couples with male
factor infertility; and the short … What are the short- and long-term health
outcomes of donors in infertility?
– KQ 6a. … Do specific aspects of the pre-donation
evaluation identify potential donors
at greater risk for short … Do short- and long-term outcomes differ
among different stimulation/retrieval
protocols? … All other short-
and long-term outcomes had insufficient SOE or
were not evaluated in the limited set
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
January 01, 2017 - Across these small, short-term studies, coblation
tonsillectomy was generally associated with faster … (12
months)
Fewer throat infections in
tonsillectomy arms in short-term
3 RCT (260)
1 Non-RCT … term (≤12
months)
Fewer streptococcal infections in
tonsillectomy arms in short-term
2 RCT (203 … Despite the large body of literature, most
evidence addresses effects in the short term. … This short-term improvement must be weighed
against a roughly 4 percent frequency of PTH.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
August 22, 2008 - It is FDA approved for the treatment of growth hormone deficiency, idiopathic short
stature, Turner … 5 evaluation if they are 1) studies of rhGH therapy, 2) conducted in
patients with CF, idiopathic short … of rhGH
utilized, length of study, duration of patient followup, and disease state (CF, idiopathic short … Or/ 45 – 49
51. idiopathic short stature.mp.
52. … Or/ 20 – 24
26. idiopathic short stature.mp.
27.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
August 01, 2007 - Objective: To assess the short-term mortality in a population-based cohort of all British
Columbia seniors … We sought to assess the short-term mortality in a population-based cohort of all British
Columbia seniors … Potential mechanisms through which conventional APMs might increase short-term mortality
are speculative … Evaluating short-term drug effects in claims
databases using physician-specific prescribing
preferences … Simultaneous assessment of short-term
gastrointestinal benefits and cardiovascular risks of
selective
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
May 01, 2015 - Executive Summary
Introduction
Ankyloglossia is a congenital condition
characterized by an abnormally short … Some propose that a short frenulum elongates
spontaneously due to progressive stretching and thinning … frenulum with age and use.1 However, there are no
prospective longitudinal data on the congenitally short … Harms
We considered the strength of evidence for minimal
and short-lived bleeding as a minor harm … BSES –SF = Breastfeeding Self-Efficacy Scale-Short Form; IBFAT = Infant Breastfeeding Assessment Tool
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
August 09, 2012 - Within category B, stakeholders
emphasized measurement of both short- and long-term outcomes and the … Within
category B, stakeholders prioritized standardized measurement and collection of data on short … Development of standardized measures for short- and long-term maternal and infant
outcomes.
2. … Short- and long-term
outcomes after cesarean section. … Development of standardized measures for short and long-term maternal and infant
outcomes
2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
September 30, 2015 - muscle relaxant use: 41.48% vs. 36.06%
Opioid type in first 180 days
Long-acting only: 1.44% vs. 2.21%
Short-acting … 90.58%
Combination: 12.89% vs. 7.22%
Opioid type in second 180 days
Long-acting only: 2.59% vs. 2.6%
Short-acting … opioid-related adverse event, 1:1 matching based on age and time of cohort entry
Dose: Long-acting, short-acting … , and short- and long-acting opioids, Daily MME categorized as <20, 20-50, and ≥120 mg Mean age: 77 years … Race, sex, geographic region, economic status, comorbidities, other medications Opioid formulation, short-acting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
February 01, 2013 - 5
What is the effectiveness of the following treatment strategies on short-, intermediate- or long- … High (women and men) for short-
term (30-day) composite outcomes
2. … Low (women) and high (men) for
short-term (6-month) composite
outcomes
2. … Low (women and men) for short-term
(30-day) composite outcomes
2. … What is the effectiveness of the following treatment strategies on short-,
intermediate- or long-term
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ankyloglossia_research-protocol.pdf
June 30, 2014 - Systematic Review
Background
Ankyloglossia is a congenital condition characterized by an abnormally short … inspection but is thought to be
tight on manual palpation or is found to be abnormally prominent, short … Some propose that a short frenulum elongates
spontaneously due to progressive stretching and thinning … age and use.1
However, there are no prospective longitudinal data on the fate of the congenitally short … failure of conservative
measures should be a priority to prevent unnecessary procedures and optimize short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-executive-summary.pdf
July 01, 2024 - • Harms reporting was limited by sample sizes and short followup duration though
most studies did … endometrial stimulation as measured by transvaginal
ultrasound or endometrial biopsy in primarily short-term … Studies of specific interventions or direct
comparisons were few, small, short, and often lacked methodologic … inconsistently reported but there was not a strong signal for
frequent serious adverse effects in short-term
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
November 26, 2024 - prescription stimulant
medications in adults to understand the patterns / trends in misuse and the short … Exposure
Specific prescription stimulant(s), if named
• Comparator, if applicable
• Outcome
o Short-term … IndexTermsFilt: ("Health
Outcomes")) OR (IndexTermsFilt: ("Mental Health Outcomes"))) OR ((title: ("short … consequence)) OR (title: (consequences)) OR (title:
(sequala)) OR (title: (sequalae))) OR ((abstract: ("short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - One unique
indication, asymptomatic short cervix, had a randomized
trial of progesterone vaginal gel … number of prior spontaneous preterm births, gestational
age at initiation of the intervention, or a short … Two
RCTs report effectiveness in reducing preterm birth among
women with short cervical length. … Two trials among women with
short cervical length provide low strength of evidence for
effectiveness … Progesterone and the risk of
preterm birth among women with a short cervix.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
December 31, 2014 - successfully from an inpatient to an
outpatient setting (e.g., discharge services, followup calls, short-term … of stay (LOS) is efficacious and cost-effective; however,
whether such analyses adequately consider short … Short stays may not permit psychiatric professionals to develop adequate discharge
plans, particularly … hospital care or serve as part of the discharge process and, depending on
availability, may include short … support services: coordinated care and support services (e.g., discharge services,
followup calls, short-term
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Key Question 1: Benefits of cannabinoids for chronic pain compared with placebo in the
short term (4 … Key Question 2: Harms of cannabinoids for chronic pain compared with placebo in the
short term (4 weeks … Our methods
included categorizing the duration of studies as short-, intermediate-, and long-term. … Only short-term evidence is available for cannabis-related interventions
containing THC and/or CBD to … Form
Survey; SF-36 PF = 36 Item Short Form Survey Physical Functioning; THC = tetrahydrocannabinol.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
September 02, 2016 - KQ 6: What are the short- and long-term health outcomes of donors in infertility?
a. … Do short- and long-term outcomes differ among different induction/retrieval
protocols? … § Calendar time (months)
§ Number of cycles
o Costs
§ Patient
§ Health system
§ Societal
o Short-term … for oocyte donation
• Comparators (men)
o Men who do not donate semen
• Outcomes (women):
o Short-term … 16
o Quality-of-life outcomes
• Outcomes (men):
o Quality-of-life outcomes
• Timing :
o Short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - muscle relaxant use: 41.48% vs. 36.06%
Opioid type in first 180 days
Long-acting only: 1.44% vs. 2.21%
Short-acting … 90.58%
Combination: 12.89% vs. 7.22%
Opioid type in second 180 days
Long-acting only: 2.59% vs. 2.6%
Short-acting … opioid-related adverse event, 1:1 matching based on age and time of cohort entry
Dose: Long-acting, short-acting … , and short- and long-acting opioids, Daily MME categorized as <20, 20-50, and ≥120 mg Mean age: 77 years … Race, sex, geographic region, economic status, comorbidities, other medications Opioid formulation, short-acting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - and Drug Administration (FDA) has
approved several prescription drugs for insomnia, typically
for short-term … receptor antagonist (suvorexant) improved
some outcomes among the general adult population in
primarily short-term … With Placebo:
Main Findings
Note: Most studies of pharmacological interventions were small and of short … www.absm.org/bsmspecialists.aspx.
�� Some medications appear to be effective for insomnia
in the short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - Key Questions not only addressed short-term
efficacy and safety but also assessed longer term benefits … Key Points
• RCT results were limited to short-term efficacy studies
versus placebo or usual care ( … Short-Term Harms
We evaluated three measures of short-term treatment
harms from randomized placebo controlled … Short-term adverse effects from treatment with dopamine
agonists compared with placebo were nausea ( … Yet,
16
evidence is limited to short-term efficacy trials or
observational studies among highly